131 related articles for article (PubMed ID: 8612312)
1. A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment.
Raaphorst GP; Doja S; Davis L; Stewart D; Ng CE
Cancer Chemother Pharmacol; 1996; 37(6):574-80. PubMed ID: 8612312
[TBL] [Abstract][Full Text] [Related]
2. Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment.
Raaphorst GP; Chabot P; Doja S; Wilkins D; Stewart D; Ng CE
Int J Hyperthermia; 1996; 12(2):211-22. PubMed ID: 8926390
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cross-resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance.
Raaphorst GP; Wilkins DE; Mao JP; Miao JC; Ng CE
Radiat Oncol Investig; 1999; 7(3):153-7. PubMed ID: 10406056
[TBL] [Abstract][Full Text] [Related]
4. Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells.
Raaphorst GP; Miao J; Stewart D; Ng CE
Cancer Chemother Pharmacol; 1998; 41(6):491-6. PubMed ID: 9554594
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells.
Raaphorst GP; Miao J; Ng CE
Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189
[TBL] [Abstract][Full Text] [Related]
6. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
Chen G; Zeller WJ; Todorov DK
Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of apoptosis in four human tumour cell lines with differing sensitivities to cisplatin.
Raaphorst GP; Mao J; Yang H; Goel R; Niknafs B; Shirazi FH; Yazdi HM; Rippstein P; Ng CE
Anticancer Res; 1998; 18(4C):2945-51. PubMed ID: 9713489
[TBL] [Abstract][Full Text] [Related]
8. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines.
Raaphorst GP; Yang H; Wilkins DE; Ng CE
Int J Hyperthermia; 1996; 12(6):801-12. PubMed ID: 8950160
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells.
Beketić-Oresković L; Jaksić M; Oresković S; Osmak M
Int J Hyperthermia; 1997; 13(2):205-14. PubMed ID: 9147146
[TBL] [Abstract][Full Text] [Related]
11. Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.
Jones E; Alvarez Secord A; Prosnitz LR; Samulski TV; Oleson JR; Berchuck A; Clarke-Pearson D; Soper J; Dewhirst MW; Vujaskovic Z
Int J Hyperthermia; 2006 Mar; 22(2):161-72. PubMed ID: 16754599
[TBL] [Abstract][Full Text] [Related]
12. Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin.
Raaphorst GP; Maio J; Ng CE; Stewart DJ
Oncol Rep; 1998; 5(4):971-7. PubMed ID: 9625857
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase inhibition and hyperthermia for the potentiation of the cytotoxic response in ovarian cancer cells.
Barnes AP; Miller BE; Kucera GL
Gynecol Oncol; 2007 Feb; 104(2):443-50. PubMed ID: 16996114
[TBL] [Abstract][Full Text] [Related]
14. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines.
van de Vaart PJ; van der Vange N; Zoetmulder FA; van Goethem AR; van Tellingen O; ten Bokkel Huinink WW; Beijnen JH; Bartelink H; Begg AC
Eur J Cancer; 1998 Jan; 34(1):148-54. PubMed ID: 9624250
[TBL] [Abstract][Full Text] [Related]
16. Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.
Herman TS; Teicher BA; Cathcart KN; Kaufmann ME; Lee JB; Lee MH
Cancer Res; 1988 Sep; 48(18):5101-5. PubMed ID: 3409235
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia enhanced chemosensitivity of human malignant glioma cells.
Hermisson M; Weller M
Anticancer Res; 2000; 20(3A):1819-23. PubMed ID: 10928113
[TBL] [Abstract][Full Text] [Related]
18. Radiation enhanced efficiency of combined electromagnetic hyperthermia and chemotherapy of lung carcinoma using cisplatin functionalized magnetic nanoparticles.
Babincová M; Kontrisova K; Durdík S; Bergemann C; Sourivong P
Pharmazie; 2014 Feb; 69(2):128-31. PubMed ID: 24640602
[TBL] [Abstract][Full Text] [Related]
19. Thermal behavior of a human glioma cell line and its response to combinations of hyperthermia and lonidamine.
Floridi A; Gentile FP; Bruno T; Delpino A; Iacobini C; Paggi MG; Castiglione S; Benassi M
Oncol Res; 1993; 5(1):1-10. PubMed ID: 8369571
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of thermal cisplatin sensitization in normal and XP human cells using mild hyperthermia at 40 and 41 degrees C.
Raaphorst GP; Yang DP
Anticancer Res; 2005; 25(4):2649-53. PubMed ID: 16080507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
